Medicinova (MNOV) Long-Term Debt Issuances (2010 - 2011)

Medicinova's (MNOV) quarterly Long-Term Debt Issuances came in at $15.9 million in Q2 2011, up 1949.03% on a QoQ basis from -$857619.0 in Q1 2011.

Medicinova (MNOV) Long-Term Debt Issuances (2010 - 2011) Analysis & Trends

Medicinova (MNOV) has 2 years of Long-Term Debt Issuances data on file, last reported at $15.9 million in Q2 2011.

On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $15.9 million in Q2 2011; TTM through Dec 2011 was $15.0 million, a N/A change from a year earlier, with the FY2011 full-year figure at $15.0 million, up 2.25% from the prior year.
Long-Term Debt Issuances for Q2 2011 stood at $15.9 million, up from -$857619.0 in the prior quarter.
Over the last five years, Long-Term Debt Issuances for MNOV reached as high as $15.9 million in Q2 2011 and fell as low as -$857619.0 in Q1 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Medicinova	64.48 Mn	64.48 Mn	4,754.00	-

Download Data